The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]

  • See Evidence submitted by expert panel for details.

Variant: NM_030662.3(MAP2K2):c.690G>A (p.Thr230=)

CA291996

138159 (ClinVar)

Gene: MAP2K2
Condition: RASopathy
Inheritance Mode: Autosomal dominant inheritance
UUID: 76788912-f5e9-4ff4-8343-c7b0c152c0b2
Approved on: 2018-11-15
Published on: 2018-12-10

HGVS expressions

NM_030662.3:c.690G>A
NM_030662.3(MAP2K2):c.690G>A (p.Thr230=)
ENST00000262948.9:c.690G>A
ENST00000394867.8:c.399G>A
ENST00000593364.5:n.637G>A
ENST00000597008.5:n.291G>A
ENST00000597263.5:n.154G>A
ENST00000599021.1:n.14G>A
ENST00000601786.5:n.991G>A
ENST00000602167.5:n.410G>A
NC_000019.10:g.4101034C>T
CM000681.2:g.4101034C>T
NC_000019.9:g.4101032C>T
CM000681.1:g.4101032C>T
NC_000019.8:g.4052032C>T
NG_007996.1:g.28095G>A
More

Benign

Met criteria codes 1
BA1

Evidence Links 0

Expert Panel

Criteria Specification Information

Criteria Specifications for this VCEP
Evidence submitted by expert panel
RASopathy VCEP
The filtering allele frequency of the c.690G>A (p.Thr230=) variant in the MAP2K2 gene is 0.1273% for Latino chromosomes by the Exome Aggregation Consortium (3/642 with 95% CI), which is a high enough frequency to be classified as benign based on thresholds defined by the ClinGen RASopathy Expert panel for autosomal dominant RASopathy variants (BA1).
Met criteria codes
BA1
The filtering allele frequency of the c.690G>A (p.Thr230=) variant in the MAP2K2 gene is 0.1273% for Latino chromosomes by the Exome Aggregation Consortium (3/642 with 95% CI), which is a high enough frequency to be classified as benign based on thresholds defined by the ClinGen RASopathy Expert panel for autosomal dominant RASopathy variants (BA1).
Curation History
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
¤ Powered by BCM's Genboree.